• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体在甲状腺乳头状癌中的预后影响

Prognostic impact of EGF-receptor in papillary thyroid carcinoma.

作者信息

Akslen L A, Myking A O, Salvesen H, Varhaug J E

机构信息

Department of Pathology, Gade Institute, Bergen, Norway.

出版信息

Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432.

DOI:10.1038/bjc.1993.432
PMID:8398712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1968597/
Abstract

In this study of papillary thyroid carcinomas, immunopositivity for EGF-receptor was present in a majority of the cases (96%), although different staining patterns were observed. A distinct membraneous reaction was found in 46%, whereas cytoplasmatic positivity of various degrees was present in 90% of the cases. Strong cytoplasmic EGF-receptor staining was significantly associated with extra-thyroidal growth of the primary tumour (P = 0.009), and it was furthermore related to decreased recurrence free survival (P = 0.006). Membraneous EGF-receptor staining was not associated with recurrence free survival or patient survival. Multivariate Cox analysis showed that lymph node metastases (P = 0.0009) and cytoplasmic EGF-receptor staining (P = 0.0048) was independent indicators of tumour recurrences in this group of surgically treated papillary thyroid carcinomas.

摘要

在这项关于甲状腺乳头状癌的研究中,尽管观察到不同的染色模式,但大多数病例(96%)中存在表皮生长因子受体免疫阳性。46%的病例中发现有明显的膜反应,而90%的病例存在不同程度的细胞质阳性。强烈的细胞质表皮生长因子受体染色与原发性肿瘤的甲状腺外生长显著相关(P = 0.009),此外还与无复发生存率降低有关(P = 0.006)。膜表皮生长因子受体染色与无复发生存率或患者生存率无关。多变量Cox分析显示,在这组接受手术治疗的甲状腺乳头状癌中,淋巴结转移(P = 0.0009)和细胞质表皮生长因子受体染色(P = 0.0048)是肿瘤复发的独立指标。

相似文献

1
Prognostic impact of EGF-receptor in papillary thyroid carcinoma.表皮生长因子受体在甲状腺乳头状癌中的预后影响
Br J Cancer. 1993 Oct;68(4):808-12. doi: 10.1038/bjc.1993.432.
2
Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.乳头状甲状腺癌中的癌蛋白与肿瘤进展:表皮生长因子受体、c-erbB-2蛋白、雌激素受体相关蛋白、p21-ras蛋白的存在以及与肿瘤复发和患者生存相关的增殖指标
Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#.
3
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.甲状腺乳头状癌中各种临床病理特征的预后重要性
Eur J Cancer. 1992;29A(1):44-51. doi: 10.1016/0959-8049(93)90574-y.
4
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
5
Prognostic importance of sclerosing variant in papillary thyroid carcinoma.甲状腺乳头状癌中硬化型变体的预后重要性。
Am Surg. 2006 May;72(5):438-44.
6
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
7
Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.甲状腺乳头状癌和滤泡状癌的早期复发预示着更差的预后。
Thyroid. 2009 Oct;19(10):1053-9. doi: 10.1089/thy.2009.0133.
8
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.程序性死亡配体1过表达是侵袭性乳头状甲状腺癌及其变异型的一个预后标志物。
Oncotarget. 2016 May 31;7(22):32318-28. doi: 10.18632/oncotarget.8698.
9
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
10
Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.血管侵犯是甲状腺乳头状癌远处无复发生存的独立预后因素:一项配对病例对照研究。
J Clin Pathol. 2016 Oct;69(10):872-7. doi: 10.1136/jclinpath-2015-203547. Epub 2016 Mar 24.

引用本文的文献

1
Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays.胆管癌的术后预后预测因子:组织微阵列的临床分析和免疫测定。
Gut Liver. 2023 Jan 15;17(1):159-169. doi: 10.5009/gnl220044. Epub 2022 Nov 1.
2
Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study.年轻增加了甲状腺乳头状癌患者淋巴结阳性的风险:一项基于监测、流行病学和最终结果(SEER)数据库的研究。
Cancer Manag Res. 2018 Sep 25;10:3867-3873. doi: 10.2147/CMAR.S167774. eCollection 2018.
3
Expression of the estrogen receptor α, progesterone receptor and epidermal growth factor receptor in papillary thyroid carcinoma tissues.

本文引用的文献

1
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.乳腺肿瘤活检中表皮生长因子结合情况及其与雌激素受体和孕激素受体水平的关系。
Cancer Res. 1984 Aug;44(8):3448-53.
2
Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells.表皮生长因子对人克隆性胶质瘤细胞培养物中膜运动性和细胞移动的影响。
J Neurosci Res. 1982;8(2-3):491-507. doi: 10.1002/jnr.490080236.
3
Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy.
雌激素受体α、孕激素受体及表皮生长因子受体在甲状腺乳头状癌组织中的表达
Oncol Lett. 2015 Jul;10(1):317-320. doi: 10.3892/ol.2015.3223. Epub 2015 May 19.
4
Anaplastic thyroid carcinoma.间变性甲状腺癌。
Front Endocrinol (Lausanne). 2012 Jul 5;3:84. doi: 10.3389/fendo.2012.00084. eCollection 2012.
5
EGF and TGF-β1 Effects on Thyroid Function.表皮生长因子和转化生长因子-β1对甲状腺功能的影响。
J Thyroid Res. 2011;2011:431718. doi: 10.4061/2011/431718. Epub 2011 Jun 13.
6
Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.间变性甲状腺癌:当前及未来治疗选择的全面综述
World J Clin Oncol. 2011 Mar 10;2(3):150-7. doi: 10.5306/wjco.v2.i3.150.
7
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.在甲状腺癌细胞系中,periostin 基因的表达受 p73 控制,与活跃转录的表观遗传标记无关。
Cell Oncol (Dordr). 2011 Apr;34(2):131-40. doi: 10.1007/s13402-011-0009-9. Epub 2011 Jan 27.
8
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.胰腺导管腺癌的细胞膜和细胞质表皮生长因子受体表达。
Med Oncol. 2012 Mar;29(1):134-9. doi: 10.1007/s12032-010-9802-y. Epub 2011 Jan 25.
9
Multi-targeted approach in the treatment of thyroid cancer.甲状腺癌治疗中的多靶点方法。
Minerva Chir. 2010 Feb;65(1):59-69.
10
Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.西妥昔单抗和AEE 788对甲状腺癌细胞系中表皮生长因子受体(EGF-R)和血管内皮生长因子受体(VEGF-R)的不同作用
Endocrine. 2007 Apr;31(2):105-13. doi: 10.1007/s12020-007-0008-9.
甲状腺乳头状癌。对意大利佛罗伦萨大学治疗的241例病例的临床病理研究。
Cancer. 1985 Feb 15;55(4):805-28. doi: 10.1002/1097-0142(19850215)55:4<805::aid-cncr2820550419>3.0.co;2-z.
4
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma.分化型甲状腺癌患者的长期结果及预后因素
Cancer. 1985 Feb 15;55(4):794-804. doi: 10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z.
5
Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.癌基因在甲状腺肿瘤中的表达:c-erbB2/neu与c-erbB的共表达
Br J Cancer. 1988 Apr;57(4):358-63. doi: 10.1038/bjc.1988.82.
6
Receptors for epidermal growth factor and thyrotropin in thyroid carcinoma.甲状腺癌中表皮生长因子和促甲状腺激素的受体
Acta Endocrinol (Copenh). 1988 Jan;117(1):45-50. doi: 10.1530/acta.0.1170045.
7
Epidermal growth factor receptor on human thyroid neoplasms.人类甲状腺肿瘤上的表皮生长因子受体
World J Surg. 1988 Oct;12(5):616-22. doi: 10.1007/BF01655864.
8
Epidermal growth factor receptors in normal and neoplastic thyroid tissue.正常和肿瘤性甲状腺组织中的表皮生长因子受体
Surgery. 1985 Dec;98(6):1000-7.
9
Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years.甲状腺乳头状癌、滤泡状癌和髓样癌的预后因素。对216例患者进行回顾性多变量分析,中位随访时间为11年。
Acta Radiol Oncol. 1985 Jan-Feb;24(1):17-24. doi: 10.3109/02841868509134360.
10
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.表皮生长因子受体状态作为乳腺癌早期复发和死亡的预测指标
Lancet. 1987 Jun 20;1(8547):1398-402. doi: 10.1016/s0140-6736(87)90593-9.